These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33607683)

  • 1. Two Rare Causes of Anterior Pseudo-Uveitis Affecting the Iris: Sequelae of Bilateral Acute Iris Transillumination (BAIT) Syndrome and Iridocorneal Endothelial (ICE) Syndrome.
    Papasavvas I; LeHoang P; Herbort CP
    Klin Monbl Augenheilkd; 2021 Apr; 238(4):443-447. PubMed ID: 33607683
    [No Abstract]   [Full Text] [Related]  

  • 2. Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
    Gonul S; Bakbak B
    Ocul Immunol Inflamm; 2022 Jan; 30(1):244-245. PubMed ID: 32946301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral acute iris depigmentation and bilateral acute iris transillumination syndrome.
    Rueda-Rueda T; Sánchez-Vicente LJ; Moruno-Rodríguez A; Monge-Esquivel J; Muñoz-Morales A; López-Herrero F
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Jul; 94(7):355-358. PubMed ID: 30876733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral Acute Iris Transillumination (BAIT): A Rare Syndrome Possibly Associated with COVID-19 and Moxifloxacin Use. A Report of 2 Cases.
    Lončarić K; Tadić R; Radmilović M; Vatavuk Z
    Semin Ophthalmol; 2023 Apr; 38(3):312-315. PubMed ID: 36653737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Associated Bilateral Acute Iris Transillumination.
    Yagci BA; Atas F; Kaya M; Arikan G
    Ocul Immunol Inflamm; 2021 May; 29(4):719-721. PubMed ID: 34124990
    [No Abstract]   [Full Text] [Related]  

  • 6. [Moxiflaxin and iris transillumination].
    Broens A; Collignon N
    Rev Med Liege; 2016 Jul; 71(7-8):321-323. PubMed ID: 28383838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use.
    Gorbea Fuxench GA; Ayala Rodríguez SC; Guardiola G; Ramos F; Pappaterra-Rodríguez M; Requejo Figueroa GA; Llop SM; Santiago LA; Santos C; Oliver AL
    Ocul Immunol Inflamm; 2024 Sep; 32(7):1368-1373. PubMed ID: 37652695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral acute iris transillumination (BAIT) syndrome: Differential diagnosis based on clinical, OCT and UBM findings.
    Cronemberger S; Vasconcelos-Santos DV; Correia de Carvalho C; Carvalho JH; Calixto J; Diniz-Filho A
    Eur J Ophthalmol; 2024 Jan; 34(1):NP22-NP26. PubMed ID: 37160763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral acute iris transillumination (BAIT) initially misdiagnosed as acute iridocyclitis.
    Gonul S; Bozkurt B
    Arq Bras Oftalmol; 2015; 78(2):115-7. PubMed ID: 25945534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-An Update.
    Tuğal-Tutkun İ; Altan Ç
    Turk J Ophthalmol; 2022 Oct; 52(5):342-347. PubMed ID: 36317812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral acute iris transillumination following a fumigation therapy: a village-based traditional method for the treatment of ophthalmomyiasis.
    Gonul S; Bozkurt B; Okudan S; Tugal-Tutkun I
    Cutan Ocul Toxicol; 2015 Mar; 34(1):80-3. PubMed ID: 24678751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)Following Acute COVID-19 Infection.
    Altan C; Basarir B; Bayraktar S; Tugal-Tutkun I
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1163-1168. PubMed ID: 36083696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe sequelae in bilateral acute iris transillumination syndrome secondary to the use of oral moxifloxacin: a case report.
    Rivera-Valdivia N; Arteaga-Rivera K; Reyes-Guanes J; Neira-Segura N; de-la-Torre A
    J Med Case Rep; 2021 Sep; 15(1):462. PubMed ID: 34537056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral acute Iris transillumination after COVID-19 pneumonia.
    Yüksel M; Özdemir HB; Özdek Ş; Gürelik G
    Eur J Ophthalmol; 2023 Jul; 33(4):NP115-NP118. PubMed ID: 35850544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral acute iris transillumination (BAIT) syndrome: literature review.
    Perone JM; Chaussard D; Hayek G
    Clin Ophthalmol; 2019; 13():935-943. PubMed ID: 31239635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral Acute Iris Transillumination: A Rare Cause of Iris Atrophy. Report of 2 Cases.
    Jang L; Borruat FX; Guex-Crosier Y
    Klin Monbl Augenheilkd; 2015 Apr; 232(4):593-4. PubMed ID: 25902135
    [No Abstract]   [Full Text] [Related]  

  • 17. Bilateral acute iris transillumination syndrome. A case report.
    Plaza-Ramos P; Heras-Mulero H; Fanlo P; Zubicoa A
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep; 93(9):447-450. PubMed ID: 29398234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unusual anisocoria].
    Klonner J; Salchow D
    Ophthalmologe; 2021 Jun; 118(6):597-599. PubMed ID: 32588124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral Acute Iris Transillumination and Elevated Intraocular Pressure After COVID-19 Infection.
    Gulmez Sevim D; Sener H; Evereklioglu C
    J Glaucoma; 2023 Jun; 32(6):e56-e59. PubMed ID: 36946913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Moxifloxacin and iris transillumination].
    Broens A; Collignon N
    Rev Med Liege; 2015 Dec; 70(12):606-8. PubMed ID: 26867304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.